Phase 2
💊 Investigational Drug / Biologic
NCT06651593
🟢 NCI-Designated Comprehensive Center
MD Anderson Cancer Center
📍 Houston, Texas • Clinical Trial Intake Hotline: (877) 632-6789
The University of Texas MD Anderson Cancer Center in Houston is globally recognized for pioneering oncology care, specialized clinical trials, and cancer prevention programs.
Active Clinical Trials at MD Anderson Cancer Center
Explore currently recruiting research protocols registered with the NIH ClinicalTrials.gov database:
Phase 2
💊 Investigational Drug / Biologic
NCT07325253
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
View Protocol & Screener ➔
Protocol / Phase N/A
📋 Clinical Research Protocol
NCT07283653
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
View Protocol & Screener ➔
Not Applicable
📊 Observational Clinical Research
NCT06295783
Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect
View Protocol & Screener ➔
Not Applicable
📊 Observational Clinical Research
NCT01728545
The Collection and Storage of Umbilical Cord Blood for Transplantation
View Protocol & Screener ➔
Phase 1
💊 Investigational Drug / Biologic
NCT06414902